Piper Sandler initiated coverage on Infinity Pharmaceuticals with a new price target

2/18/21 6:04:35 AM ET

Biotechnology: Pharmaceutical Preparations

Health Care

Piper Sandler initiated coverage of Infinity Pharmaceuticals with a rating of Overweight and set a new price target of $7.00

Save time and jump to the most important pieces.

Recent Analyst Ratings for
$INFI

Date	Price Target	Rating	Analyst
10/18/2021	$9.00	Buy	HC Wainwright & Co.
8/2/2021	$6.00	Neutral → Overweight	JP Morgan
7/28/2021	$4.00 → $14.00	Equal-Weight → Overweight	Wells Fargo
7/7/2021	$7.00	Buy	B. Riley Securities